Nome Químico: 2,2`-[(3-Methylpentane-1,5-diyl)bis[oxy(3-oxopropane-3,1-diyl)]]bis[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] dibenzenesulfonate (as per EP)
Sorrisos: O=S(C1=CC=CC=C1)([O-])=O.O=S(C2=CC=CC=C2)([O-])=O.CC(CCOC(CC[N@+]3(C)[C@H](CC4=CC=C(OC)C(OC)=C4)C5=C(C=C(OC)C(OC)=C5)CC3)=O)CCOC(CC[N@+]6(C)[C@H](CC7=CC=C(OC)C(OC)=C7)C8=C(C=C(OC)C(OC)=C8)CC6)=O
Inchi: InChI=1S/C54H74N2O12.2C6H6O3S/c1-36(68-54(58)22-26-56(3)24-20-40-33-50(64-9)52(66-11)35-42(40)44(56)29-38-16-18-46(60-5)48(31-38)62-7)14-12-13-27-67-53(57)21-25-55(2)23-19-39-32-49(63-8)51(65-10)34-41(39)43(55)28-37-15-17-45(59-4)47(30-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h15-18,30-36,43-44H,12-14,19-29H2,1-11H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t36?,43-,44-,55-,56-;;/m1../s1
HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products
By Zhang H; Wang P; Bartlett M G; Stewart J T
From Journal of pharmaceutical and biomedical analysis (1998), 16(7), 1241-9